207 related articles for article (PubMed ID: 28400351)
1. Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome.
Karaköse M; Hepsen S; Çakal E; Saykı Arslan M; Tutal E; Akın Ş; Ünsal İ; Özbek M
J Turk Ger Gynecol Assoc; 2017 Jun; 18(2):85-89. PubMed ID: 28400351
[TBL] [Abstract][Full Text] [Related]
2. Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome.
Duran C; Basaran M; Kutlu O; Kucukaydin Z; Bakdik S; Burnik FS; Aslan U; Erdem SS; Ecirli S
Endocrine; 2015 Jun; 49(2):464-9. PubMed ID: 25522724
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
4. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
5. The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.
Yin D; Ruan X; Tian X; Du J; Zhao Y; Cui Y; Li Y; Mueck AO
Gynecol Endocrinol; 2017 Apr; 33(4):332-335. PubMed ID: 28051891
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
7. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
8. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
9. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
10. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome.
Kumar AN; Naidu JN; Satyanarayana U; Ramalingam K; Anitha M
Int J Fertil Steril; 2016; 10(1):22-8. PubMed ID: 27123196
[TBL] [Abstract][Full Text] [Related]
12. Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
Sahin M; Demircioglu D; Oguz A; Tuzun D; Sarica MA; Inanc E; Gul K
Arch Endocrinol Metab; 2017; 61(2):145-151. PubMed ID: 27901182
[TBL] [Abstract][Full Text] [Related]
13. An assessment of the relationship between thyroid nodule characteristics, insulin resistance and arterial stiffness in euthyroid nodular goiter.
Aydoğan Y; Altay M; Ünsal O; Kaplanoğlu V; Çağır Y; Yıldız C; Beyan E; Ramadan SU
Endocrine; 2018 Nov; 62(2):440-447. PubMed ID: 30084100
[TBL] [Abstract][Full Text] [Related]
14. Thyroid Disorders in Young Females with Polycystic Ovary Syndrome and Correlation of Thyroid Volume with Certain Hormonal Parameters.
Polat SB; Oğuz O; Sacikara M; Cuhaci FN; Evranos B; Ersoy R; Cakir B
J Reprod Med; 2016; 61(1-2):27-32. PubMed ID: 26995885
[TBL] [Abstract][Full Text] [Related]
15. Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls.
Kim JJ; Yoon JW; Kim MJ; Kim SM; Hwang KR; Choi YM
Hum Fertil (Camb); 2022 Feb; 25(1):128-134. PubMed ID: 31910041
[TBL] [Abstract][Full Text] [Related]
16. [High frequency of thyroid abnormalities in polycystic ovary syndrome].
Calvar CE; Bengolea SV; Deutsch SI; Hermes R; Ramos G; Loyato M
Medicina (B Aires); 2015; 75(4):213-7. PubMed ID: 26339875
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F
Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
[TBL] [Abstract][Full Text] [Related]
18. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
Chen Y; Wang XJ; Jin HL; Jin L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role?
Arduc A; Aycicek Dogan B; Bilmez S; Imga Nasiroglu N; Tuna MM; Isik S; Berker D; Guler S
Endocr Res; 2015; 40(4):204-10. PubMed ID: 25822940
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
